Comparison of Inpatient Glycemic Control by Continuous Glucose Monitoring (CGM) and Capillary Point-Of-Care (POC) Testing in General Medicine Patients With Type 2 Diabetes Treated With Basal Bolus Insulin Regimen

被引:0
|
作者
Gomez, Ana M.
Umpierrez, Guillermo E.
Aschner, Pablo
Herrera, Felipe
Rubio, Claudia P.
Manoz, Oscar
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
898-P
引用
收藏
页码:A227 / A227
页数:1
相关论文
共 50 条
  • [11] Continuous Glucose Monitoring Improved Glycemic Control in Patients with Type 1 Diabetes in a 52-Week Period, either with Insulin Pump Therapy or with a Basal-Bolus Insulin Regimen
    Soupal, Jan
    Petruzelkova, Lenka
    Flekac, Milan
    Skrha, Jan, Jr.
    Skrha, Jan
    Prazny, Martin
    DIABETES, 2016, 65 : A223 - A223
  • [12] Glycemic control with the basal/bolus insulin delivery system hPATCH™ measured by continuous glucose monitoring system (CGMS) in patients with type 2 diabetes mellitus
    Strange, Poul
    Kapitza, Christoph
    Schleusener, Debra
    Fein, Seymour
    DIABETES, 2007, 56 : A121 - A121
  • [13] Glycemic control with insulin glulisine versus regular human insulin in a basal-bolus regimen in patients with type 2 diabetes
    Dailey, G
    Rosenstock, J
    Moses, R
    Ways, K
    DIABETES, 2004, 53 : A121 - A121
  • [14] Continuous Glucose Monitoring in hospitalized Patients with Type 2 Diabetes during Basal-Bolus Insulin Therapy
    Schaupp, Lukas
    Neubauer, Katharina
    Mader, Julia
    Augustin, Thomas
    Spat, Stephan
    Hoell, Bernhard
    Beck, Peter
    Plank, Johannes
    Pieber, Thomas
    WIENER KLINISCHE WOCHENSCHRIFT, 2013, 125 : S15 - S15
  • [15] The effects of aging and frailty on inpatient glycemic control by continuous glucose monitoring in patients with type 2 diabetes
    Idrees, T.
    Zabala, Z. E.
    Moreno, E. M.
    Gerges, A.
    Urrutia, M. A.
    Ruiz, J. G.
    Vaughan, C.
    Vellanki, P.
    Pasquel, F. J.
    Peng, L.
    Umpierrez, G. E.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 198
  • [16] Benefits of Capillary Point-of-Care Glucose Testing and Insulin Supplementation at Bedtime in Insulin Treated Non-ICU Inpatients with Type 2 Diabetes
    Pasquel, Francisco J.
    Oyedokun, Festus
    Bean, Rachel
    Unigwe, Michael
    Smiley, Dawn
    Farrokhi, Farnoosh
    Adeel, Saira
    Jacobs, Sol
    Peng, Limin
    Umpierrez, Guillermo E.
    DIABETES, 2014, 63 : A217 - A218
  • [17] Glycemic Control Utilizing Continuous Glucose Monitoring vs. Point-of-Care Testing in Older Adults with Type 2 Diabetes in Long-Term Care Facilities
    Idrees, Thaer
    Castro-Revoredo, Iris A.
    Gavaller, Monica D.
    Oh, Hyungseok
    Zabala, Zohyra
    Moreno, Emmelin M.
    Moazzami, Bobak
    Galindo, Rodolfo J.
    Cabb, Elena
    Johnson, Theodore M.
    Peng, Limin
    Umpierrez, Guillermo
    DIABETES, 2023, 72
  • [18] Increased glycemic variability in type 2 diabetes patients treated with insulin - a real-life clinical practice, continuous glucose monitoring (CGM) study
    Craciun, Cristian-Ioan
    Craciun, Anca-Elena
    Rusu, Adriana
    Bocsan, Corina Ioana
    Hancu, Nicolae
    Buzoianu, Anca Dana
    REVISTA ROMANA DE MEDICINA DE LABORATOR, 2018, 26 (03): : 345 - 352
  • [19] Continuous glucose monitoring improved glycaemic control in patients with type 1 diabetes during 52 weeks of insulin pump therapy as well as with basal-bolus insulin regimen
    Soupal, J.
    Flekac, M.
    Petruzelkova, L.
    Skrha, J., Jr.
    Skrha, J.
    Prazny, M.
    DIABETOLOGIA, 2015, 58 : S476 - S476
  • [20] EFFECT OF TIRZEPATIDE VERSUS INSULIN DEGLUDEC ON GLYCEMIC CONTROL CAPTURED WITH CONTINUOUS GLUCOSE MONITORING IN PATIENTS WITH TYPE 2 DIABETES (SURPASS-3 CGM)
    Battelino, T.
    Bergenstal, R.
    Rodriguez, A.
    Lando, L. Fernandez
    Bray, R.
    Tong, Z.
    Brown, K.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A37 - A38